Life Sciences Campus Berlin

The Berlin Center for Gene and Cell Therapies, jointly initiated by Bayer and Charité, will be a unique hub within an inspiring biotech ecosystem. It combines a cutting-edge incubator with state-of-the-art laboratories and GMP manufacturing facilities, offices and communal spaces, as well as specialized mentoring programs to support every phase – from research to realization.

The campus is currently being built and scheduled to be opened in 2029.

Am Nordhafen 28, 12359 Berlin